Business Context and Reporting Period
This Form 6-K filing by GSK plc covers the month of August 2026. The document serves as a transaction notification regarding a purchase of company securities by a Person Discharging Managerial Responsibilities (PDMR) or a person closely associated with them.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific insider transaction and does not contain periodic financial performance data.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document solely discloses a single acquisition of American Depositary Shares (ADS) by an executive.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It includes a standard corporate description stating GSK is a global biopharma company.
Important Facts for Investors
- Transaction Type: Acquisition of notional ADS within an Executive Supplemental Savings Plan account.
- Executive Involved: Maya Martinez-Davis, President, US.
- Transaction Date: August 24, 2026.
- Volume: 9.221 ADS.
- Price: $51.7800 per ADS.
- Exchange: New York Stock Exchange (XNYS).